×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SLGL – sol-gel technologies ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SLGL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/29
08:01 am
slgl
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth [Yahoo! Finance]
Medium
Report
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth [Yahoo! Finance]
12/22
08:02 am
slgl
Sol-Gel Technologies (NASDAQ:SLGL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Sol-Gel Technologies (NASDAQ:SLGL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
12/17
04:38 pm
slgl
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
12/17
07:56 am
slgl
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease [Yahoo! Finance]
Medium
Report
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease [Yahoo! Finance]
12/17
07:00 am
slgl
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
Low
Report
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
12/11
04:23 pm
slgl
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
12/5
04:27 pm
slgl
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
11/29
03:38 pm
slgl
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
11/20/2025
07:30 am
SLGL
sol-gel technologies ltd. - ordinary shares
MISS
Report
-0.8%
sol-gel technologies ltd. - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/15
06:54 am
slgl
Form 144 Sol-Gel Technologies Filed by: Yosef Itzik
Low
Report
Form 144 Sol-Gel Technologies Filed by: Yosef Itzik
1/6
04:06 pm
slgl
Form 4 Sol-Gel Technologies For: Jan 02 Filed by: Opaleye Management Inc.
High
Report
Form 4 Sol-Gel Technologies For: Jan 02 Filed by: Opaleye Management Inc.
12/31
05:45 pm
slgl
Form 4 Sol-Gel Technologies For: Dec 29 Filed by: Opaleye Management Inc.
Low
Report
Form 4 Sol-Gel Technologies For: Dec 29 Filed by: Opaleye Management Inc.
12/29
04:05 pm
slgl
Form 4 Sol-Gel Technologies For: Dec 22 Filed by: Opaleye Management Inc.
Medium
Report
Form 4 Sol-Gel Technologies For: Dec 22 Filed by: Opaleye Management Inc.
12/19
04:05 pm
slgl
Form 4 Sol-Gel Technologies For: Dec 17 Filed by: Opaleye Management Inc.
Neutral
Report
Form 4 Sol-Gel Technologies For: Dec 17 Filed by: Opaleye Management Inc.
12/17
08:48 am
slgl
Form 6-K Sol-Gel Technologies For: Dec 17
Medium
Report
Form 6-K Sol-Gel Technologies For: Dec 17
12/16
04:05 pm
slgl
Form 4 Sol-Gel Technologies For: Dec 12 Filed by: Opaleye Management Inc.
Low
Report
Form 4 Sol-Gel Technologies For: Dec 12 Filed by: Opaleye Management Inc.
12/9
04:12 pm
slgl
Form 4 Sol-Gel Technologies For: Dec 05 Filed by: Opaleye Management Inc.
Medium
Report
Form 4 Sol-Gel Technologies For: Dec 05 Filed by: Opaleye Management Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/30
Sol Gel Technologies Ltd (NASDAQ: SLGL) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating.
13.6%
7/8 Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea 12.9%
5/28 Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo 10.1%
8/8 Form 6-K Sol-Gel Technologies For: Aug 08 9.9%
3/25 UPDATE -- Sol-Gel Technologies to Present at Upcoming 2020 Solebury Trout Virtual Investor Conference 6.6%
2/19 Sol-Gel to Present at the Cowen 40th Annual Health Care Conference 6.5%
1/7 Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020 [Seeking Alpha] 5.7%
3/19 Sol-Gel Technologies to Report Full Year 2019 Financial Results and Corporate Update 5.5%
4/13 Sol-Gel Technologies Announces Closing of Additional $5.0 Million Investment 5.3%
2/14 Form 6-K Sol-Gel Technologies For: Feb 14 5.2%
7/8 Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea 12.9%
5/28 Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo 10.1%
8/8 Form 6-K Sol-Gel Technologies For: Aug 08 9.9%
3/25 UPDATE -- Sol-Gel Technologies to Present at Upcoming 2020 Solebury Trout Virtual Investor Conference 6.6%
2/19 Sol-Gel to Present at the Cowen 40th Annual Health Care Conference 6.5%
1/7 Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020 [Seeking Alpha] 5.7%
3/19 Sol-Gel Technologies to Report Full Year 2019 Financial Results and Corporate Update 5.5%
4/13 Sol-Gel Technologies Announces Closing of Additional $5.0 Million Investment 5.3%
2/14 Form 6-K Sol-Gel Technologies For: Feb 14 5.2%
TOP News Decliners
2/13
Form 6-K Sol-Gel Technologies For: Feb 13
-39.4%
1/2 Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study in Palmoplantar Keratoderma (PPK) -10.0%
11/13 Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update -9.1%
2/6 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. -8.6%
3/9 Arkin Holdings Raises $140 Million in Second Partnership Arkin Bio-Ventures II to Invest in Groundbreaking Pharma and Biotechnology Companies -8.3%
3/6 Form 6-K Sol-Gel Technologies For: Mar 06 -7.3%
2/5 Sol-Gel Provides Product Pipeline Updates and Anticipated Milestones for 2020 -6.2%
3/3 Form 6-K Sol-Gel Technologies For: Mar 03 -4.7%
7/18 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $11.00 price target on the stock. -4.7%
2/4 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.0%
1/2 Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study in Palmoplantar Keratoderma (PPK) -10.0%
11/13 Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update -9.1%
2/6 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. -8.6%
3/9 Arkin Holdings Raises $140 Million in Second Partnership Arkin Bio-Ventures II to Invest in Groundbreaking Pharma and Biotechnology Companies -8.3%
3/6 Form 6-K Sol-Gel Technologies For: Mar 06 -7.3%
2/5 Sol-Gel Provides Product Pipeline Updates and Anticipated Milestones for 2020 -6.2%
3/3 Form 6-K Sol-Gel Technologies For: Mar 03 -4.7%
7/18 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $11.00 price target on the stock. -4.7%
2/4 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: